Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010

Vaccine
Katie GreenlandSusan J M Hahné

Abstract

We investigated a mumps outbreak within a highly vaccinated university student population in the Netherlands by conducting a retrospective cohort study among members of university societies in Delft, Leiden and Utrecht. We used an online questionnaire asking for demographic information, potential behavioural risk factors for mumps and the occurrence of mumps. Vaccine status from the national vaccination register was used. Overall, 989 students participated (20% response rate). Registered vaccination status was available for 776 individuals, of whom 760 (98%) had been vaccinated at least once and 729 (94%) at least twice. The mumps attack rate (AR) was 13.2% (95%CI 11.1-15.5%). Attending a large student party, being unvaccinated and living with more than 15 housemates were independently associated with mumps ((RR 42 (95%CI 10.1-172.4); 3.1 (95%CI 1.7-5.6) and 1.8 (95%CI 1.1-3.1), respectively). The adjusted VE estimate for two doses of MMR was 68% (95%CI 41-82%). We did not identify additional risk factors for mumps among party attendees. The most likely cause of this outbreak was intense social mixing during the party and the dense communal living environment of the students. High coverage of MMR vaccination in childhood did no...Continue Reading

References

Dec 1, 1988·The Journal of Infectious Diseases·M WhartonW Schaffner
Oct 1, 1964·American Journal of Public Health and the Nation's Health·R J HOAGLAND
Mar 12, 2004·Annual Review of Psychology·J A Krosnick
Aug 31, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Gaynor Watson-CreedTodd F Hatchette
Oct 13, 2006·The Journal of Allergy and Clinical Immunology·Vikas S Kancherla, I Celine Hanson
Apr 5, 2008·Epidemiology and Infection·F A SoudG H Dayan
Apr 12, 2008·The New England Journal of Medicine·Gustavo H DayanJane F Seward
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Margaret M CorteseGustavo H Dayan
Oct 31, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gustavo H Dayan, Steven Rubin
Mar 13, 2009·Human Vaccines·Corinne VandermeulenKarel Hoppenbrouwers
Aug 28, 2009·The Pediatric Infectious Disease Journal·Susan HahnéHester de Melker
Mar 2, 2010·Vaccine·Heinrich J BrockhoffSusan J M Hahné
Mar 17, 2010·Vaccine·Angela DomínguezJosep Maria Jansà
Mar 24, 2010·The Pediatric Infectious Disease Journal·Norbert G SchwarzSusan Hahné
Jul 29, 2010·The Journal of Infectious Diseases·M Patricia Quinlisk
Apr 8, 2011·Emerging Infectious Diseases·Chee Fu YungMary Ramsay
Jan 21, 2012·Emerging Infectious Diseases·Susan HahnéHester de Melker

❮ Previous
Next ❯

Citations

Mar 25, 2014·Emerging Infectious Diseases·Jussi SaneSusan Hahné
Feb 28, 2014·American Journal of Epidemiology·Steven AbramsNiel Hens
Sep 3, 2013·The Pediatric Infectious Disease Journal·Preeta K KuttyGregory Wallace
May 3, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·G LadburyS Hahne
Mar 4, 2015·Open Forum Infectious Diseases·Sigrid GoumaRob S van Binnendijk
Nov 14, 2014·Médecine et maladies infectieuses·M-O VareilC Cazanave
Aug 13, 2013·The Journal of Infectious Diseases·Albert E BarskeyGregory S Wallace
Apr 5, 2013·The Pediatric Infectious Disease Journal·Stanley A Plotkin
Jun 25, 2014·Expert Review of Vaccines·Sabine Wicker, Helena C Maltezou
Mar 8, 2014·The Journal of General Virology·Sigrid GoumaRob van Binnendijk
Jun 6, 2015·Human Vaccines & Immunotherapeutics·Patricia KaaijkCécile A van Els
Nov 27, 2014·Human Vaccines & Immunotherapeutics·Qiongying YangChuanxi Fu
Oct 18, 2014·Korean journal of pediatrics·Ji-Ung RyuKyung-Yil Lee
May 10, 2013·PLoS Computational Biology·Michiel van BovenSusan Hahné
Nov 5, 2016·American Journal of Infection Control·Silvio TafuriCinzia Germinario
Jul 28, 2016·Human Vaccines & Immunotherapeutics·Sigrid GoumaRob S van Binnendijk
Nov 2, 2012·The New England Journal of Medicine·Albert E BarskeyKathleen M Gallagher
Dec 9, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leena N PatelJennifer B Rosen
Jan 11, 2017·BMC Infectious Diseases·Susan HahnéHester de Melker
Mar 28, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Loes SoetensJacco Wallinga
May 22, 2019·The Journal of Infectious Diseases·Patricia KaaijkRob S van Binnendijk
Feb 28, 2020·Clinical Microbiology Reviews·Eugene LamJane R Zucker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.